Average Co-Inventor Count = 5.42
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (25 from 2,077 patents)
2. Astex Therapeutics Limited (4 from 123 patents)
3. Other (1 from 832,761 patents)
30 patents:
1. 12492194 - HPK1 inhibitors
2. 12486264 - Bicyclic HPK1 inhibitors
3. 10894793 - Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
4. 10519137 - Pyrazolyl quinoxaline kinase inhibitors
5. 10342795 - Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives as ROS1 inhibitors
6. 10280170 - Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine derivatives as Ros1 inhibitors
7. 10202387 - Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
8. 10087187 - Imidazopyridazine derivatives as PI3KB inhibitors
9. 9850228 - Pyrazolyl quinoxaline kinase inhibitors
10. 9598396 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
11. 9464071 - Pyrazolyl quinoxaline kinase inhibitors
12. 9150540 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
13. 8946221 - Phthalazine derivatives as PARP inhibitors
14. 8895601 - Pyrazolyl quinoxaline kinase inhibitors
15. 8889866 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors